Quinolone resistance mechanisms among Extended- Spectrum Beta-Lactamase (ESBL) producing Escherichia coli isolated from rivers and lakes in Switzerland

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Zurfluh, Katrin ^a   Abgottspon, Helga ^a   Hac̈hler, Herbert ^a   Nuësch Inderbinen, Magdalena ^a   Stephan, Roger ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ASPARAGINE; ASPARTIC ACID; CEFALOTIN; CEFOTAXIME; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; GLUTAMIC ACID; ISOLEUCINE; KANAMYCIN; LEUCINE; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SERINE; STREPTOMYCIN; SULFAMETHOXAZOLE; SURFACE WATER; TETRACYCLINE; TRIMETHOPRIM; VALINE; ANTIINFECTIVE AGENT; BETA LACTAMASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; ESCHERICHIA COLI PROTEIN; QUINOLINE; QUINOLINE DERIVATIVE;

AAC 6' IB CR GENE; AAC 69 IB CR GENE; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BROTH DILUTION; CONTROLLED STUDY; ESCHERICHIA COLI; GENE MUTATION; GENE SEQUENCE; GYRA GENE; GYRB GENE; LAKE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARC GENE; PARE GENE; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; PROMOTER REGION; QEPA GENE; QNRA GENE; QNRB GENE; QNRC GENE; QNRD GENE; QNRS GENE; QNRS1 GENE; RIVER; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; SWITZERLAND; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; DNA GYRASE; DNA TOPOISOMERASE IV; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; LAKES; MICROBIAL SENSITIVITY TESTS; QUINOLINES; RIVERS; SWITZERLAND; WATER MICROBIOLOGY;

EID: 84899684357     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095864     Document Type: Article

References (44)

1. Jacoby GA (2005) Mechanisms of resistance to quinolones. Clin Infec Dis 41: S120-S126.
2. Hopkins KL, Davies RH, Threlfall EJ (2005) Mechanisms of quinolone resistance in Escherichia coli and Salmonella: Recent developments. Int J Antimicrob Agents 25: 358-373. (Pubitemid 40558766)
3. Martínez-Martínez L, Pascual A, Jacoby GA (1998) Quinolone resistance from a transferable plasmid. THE LANCET 351: 797-799. (Pubitemid 28112342)
4. Hata M, Suzuki M, Matsumoto M, Takahashi M, Sato K, et al. (2005) Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob Agents Chemother 49: 801-803. (Pubitemid 40175702)
5. Jacoby GA, Walsh KE, Mills DM, Walker VJ, Oh H, et al. (2006) qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob Agents Chemother 50: 1178-1182.
6. Wang M, Guo Q, Xu X, Wang X, Ye X, et al. (2009) New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis. Antimicrob Agents Chemother 53: 1892-1897.
7. Cavaco LM, Hasman H, Xia S, Aarestrup FM (2009) qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob Agents Chemother 53: 603-608.
8. Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, et al. (2006) Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med 12: 83-88. (Pubitemid 43050081)
9. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A (2009) Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev 22: 664-689.
10. Zurfluh K, Hächler H, Nüesch-Inderbinen M, Stephan R (2013) Characteristics of extended-spectrum β-Lactamase- and carbapenemase- producing Enterobacteriaceae isolates from rivers and lakes in Switzerland. Appl Environ Microbiol 79: 3021-3026.
11. Finley RL, Collignon P, Larsson DGJ, McEwen S a, Li X-Z, et al. (2013) The scourge of antibiotic resistance: The Important Role of the Environment. Clin Infect Dis 57: 704-710.
12. Clinical and Laboratory Standards Institute (2011) Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement, CLSI document M100-S21. Clinical and Laboratory Standards Institute, Wayne PA.
13. Kayser FH, Morenzoni G, Homberger F (1982) Activity of cefoperazone against ampicillin-resistant bacteria in agar and broth dilution tests. Antimicrob Agents Chemother 22: 15-22. (Pubitemid 12029987)
14. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, et al. (2005) Identification of plasmids by PCR-based replicon typing J Microbiol Methods 63: 219-228. (Pubitemid 41597366)
15. Rizzo L, Fiorentino A, Anselmo A (2012) Effect of solar radiation on multidrug resistant E. coli strains and antibiotic mixture photodegradation in wastewater polluted stream. Sci Total Environ 427-428: 263-268.
16. Dhanji H, Murphy NM, Akhigbe C, Doumith M, Hope R, et al. (2011) Isolation of fluoroquinolone-resistant O25b: H4-ST131 Escherichia coli with CTX-M-14 extended-spectrum β-lactamase from UK river water. J Antimicrob Chemother 66: 512-516.
17. Colomer-Lluch M, Mora A, Lopez C, Mamani R, Dahbi G, et al. (2013) Detection of quinolone-resistant Escherichia coli isolates belonging to clonal groups O25b: H4-B2-ST131 and O25b: H4-D-ST69 in raw sewage and river water in Barcelona, Spain. J Antimicrob Chemother 68: 758-765.
18. Sun J, Hu J, Peng H, Shi J, Dong Z (2012) Molecular and physiological characterization of fluoroquinolone resistance in relation to uropathogenicity among Escherichia coli isolates isolated from Wenyu River, China. Chemosphere 87: 37-42.
19. Lupo A, Coyne S, Berendonk TU (2012) Origin and evolution of antibiotic resistance: the common mechanisms of emergence and spread in water bodies. Front Microbiol 3: 1-13.
20. Vila J, Ruiz J, Marco F, Barcelo A, Goñi P, et al. (1994) Association between Double Mutation in gyrA Gene of Ciprofloxacin-Resistant Clinical Isolates of Escherichia coli and MICs. Antimicrob Agents Chemother 38: 2477-2479. (Pubitemid 24304253)
21. Sáenz Y, Zarazaga M, Briñas L, Ruiz-Larrea F, Torres C (2003) Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals. J Antimicrob Chemother 51: 1001-1005. (Pubitemid 36503435)
22. Friedman SM, Lu T, Drlica K (2001) Mutation in the DNA gyrase A gene of Escherichia coli that expands the quinolone resistance-determining region. Antimicrob Agents Chemother 45: 2378-2380. (Pubitemid 32664483)
23. Heisig P (1996) Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother 40: 879-885.
24. Ruiz J (2003) Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 51: 1109-17.
25. Rodríguez-Martínez JM, Cano ME, Velasco C, Martínez-Martínez L, Pascual A (2011) Plasmid-mediated quinolone resistance: an update. J Infect Chemother 17: 149-182.
26. Yamane K, Wachino J, Suzuki S, Kimura K, Shibata N, et al. (2007) New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother 51: 3354-3360. (Pubitemid 350067551)
27. Coque TM, Novais Â, Carattoli A, Poirel L, Pitout J, et al. (2008) Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-Lactamase CTX-M-15. Emerging Infect Dis 14: 195-200. (Pubitemid 351213667)
28. Pitout JDD, Wei Y, Church DL, Gregson DB (2008) Surveillance for plasmid-mediated quinolone resistance determinants in Enterobacteriaceae within the Calgary Health Region, Canada: the emergence of aac(6′)-Ib-cr. J Antimicrob Chemother 61: 999-1002. (Pubitemid 351524438)
29. Cattoir V, Poirel L, Mazel D, Soussy C-J, Nordmann P (2007) Vibrio splendidus as the source of plasmid-mediated QnrS-like quinolone resistance determinants. Antimicrob Agents Chemother 51: 2650-2651. (Pubitemid 47047359)
30. Picão RC, Poirel L, Demarta A, Silva CSF, Corvaglia AR, et al. (2008) Plasmid-mediated quinolone resistance in Aeromonas allosaccharophila recovered from a Swiss lake. J Antimicrob Chemother 62: 948-950.
31. Cavaco LM, Hansen DS, Friis-Møller A, Aarestrup FM, Hasman H, et al. (2007) First detection of plasmid-mediated quinolone resistance (qnrA and qnrS) in Escherichia coli strains isolated from humans in Scandinavia. J Antimicrob Chemother 59: 804-805. (Pubitemid 47073427)
32. Liassine N, Zulueta-Rodriguez P, Corbel C, Lascols C, Soussy C-J, et al. (2008) First detection of plasmid-mediated quinolone resistance in the community setting and in hospitalized patients in Switzerland. J Antimicrob Chemother 62: 1151-1152.
33. Briales A, Rodríguez-Martínez JM, Velasco C, Díaz de Alba P, Domínguez-Herrera J, et al. (2011) In vitro effect of qnrA1, qnrB1, and qnrS1 genes on gluoroquinolone activity against isogenic Escherichia coli isolates with mutations in gyrA and parC. Antimicrob Agents Chemother 55: 1266-1269.
34. Carattoli A (2009) Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother 53: 2227-2238.
35. Karczmarczyk M, Martins M, Quinn T, Leonard N, Fanning S (2011) Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing animals. Appl Environ Microbiol 77: 7113-7120.
36. Sáenz Y, Ruiz J, Zarazaga M, Teixidó M, Torres C, et al. (2004) Effect of the efflux pump inhibitor Phe-Arg-beta-naphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin. J Antimicrob Chemother 53: 544-545. (Pubitemid 38380260)
37. Sato T, Yokota S, Uchida I, Okubo T, Usui M, et al. (2013) Fluoroquinolone resistance mechanisms in an Escherichia coli isolate, HUE1, without quinolone resistance-determining region mutations. Front Microbiol 4: 1-12.
38. Poirel L, Cattoir V, Nordmann P (2012) Plasmid-mediated quinolone resistance; interactions between human, animal, and environmental ecologies. Front Microbiol 3: 1-7.
39. Cattoir V, Poirel L, Rotimi V, Soussy C, Nordmann P (2007) Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 60: 394-397. (Pubitemid 47243891)
40. Robicsek A, Strahilevitz J, Sahm DF, Jacoby GA, Hooper DC (2006) qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother 50: 2872-2874. (Pubitemid 44198719)
41. Kim HB, Park CH, Kim CJ, Kim E, Jacoby GA, et al. (2009) Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother 53: 639-645.
42. Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC (2006) Prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 50: 3953-3955. (Pubitemid 44684926)
43. Karczmarczyk M, Martins M, McCusker M, Mattar S, Amaral L, et al. (2010) Characterization of antimicrobial resistance in Salmonella enterica food and animal isolates from Colombia: identification of a qnrB19-mediated quinolone resistance marker in two novel serovars. FEMS Microbiol Lett 313: 10-19.
44. Fendukly F, Karlsson I, Hanson HS, Kronvall G, Dornbusch K (2003) Patterns of mutations in target genes in septicemia isolates of Escherichia coli and Klebsiella pneumoniae with resistance or reduced susceptibility to ciprofloxacin. APMIS 111: 857-866. (Pubitemid 37222730)